Has Jeffrey Greenberg, MD received payments from drug or device companies?

Yes. Drug and device makers reported $9,096 in general payments to Jeffrey Greenberg, MD across 419 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeffrey Greenberg, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeffrey Greenberg, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeffrey Greenberg, MD

Radiation Oncology · Plano, TXNPI 1154363117

Payments from drug & device makers

$9,096in general payments, 2019–2025

Across 419 payments — averaging $21.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$993
Johnson & Johnson$765
Daiichi Sankyo Inc.$667
Novartis$604
Teva Pharmaceuticals USA, Inc.$497
Merck$482
plus $5K from 54 others

What the payments were for

Consulting fees$2623%
Food & beverage$8,83497%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	39	$993
Johnson & Johnson	33	$765
Daiichi Sankyo Inc.	33	$667
Novartis	32	$604
Teva Pharmaceuticals USA, Inc.	43	$497
Merck	22	$482
Eisai Inc.	14	$350
Novocure Inc.	5	$337
Bayer	16	$330
Dendreon Pharmaceuticals LLC	9	$283
Genmab U.S., Inc.	7	$204
Pharmaessentia USA Corporation	6	$201
Incyte Corporation	9	$200
Jazz Pharmaceuticals Inc.	7	$199
Pfizer	9	$190
Takeda Pharmaceuticals U.S.A., Inc.	7	$163
Regeneron Healthcare Solutions, Inc.	7	$148
Sanofi	5	$130
Stemline Therapeutics Inc.	5	$130
Seagen Inc.	6	$118
Beigene USA, Inc.	4	$116
E.r. Squibb & Sons, L.L.C.	6	$114
Lilly USA, LLC	6	$108
Geron Corporation	4	$96
AVEO Pharmaceuticals, Inc.	4	$92
EMD Serono, Inc.	5	$91
Astellas Pharma US Inc	3	$82
Sobi, Inc	4	$80
Mirati Therapeutics, Inc.	3	$75
Boehringer Ingelheim	4	$73
Bristol Myers Squibb	3	$69
Servier Pharmaceuticals LLC	3	$63
Puma Biotechnology, Inc.	4	$62
Blueprint Medicines Corporation	3	$60
Rigel Pharmaceuticals, Inc.	3	$58
AbbVie	3	$58
Amgen	3	$57
GSK	3	$56
Ipsen Biopharmaceuticals, Inc	2	$50
Taiho Oncology, Inc.	2	$47
Karyopharm Therapeutics Inc.	2	$46
Exelixis Inc.	2	$41
Kyowa Kirin, Inc.	2	$40
Genentech USA, Inc.	3	$39
G1 Therapeutics, Inc.	2	$38
Pharmacyclics LLC, An Abbvie Company	2	$38
Apellis Pharmaceuticals, Inc.	2	$36
Caris MPI, Inc.	2	$34
Corium, LLC	2	$33
EUSA Pharma (US) LLC	2	$27
CTI Biopharma Corp.	1	$24
Legend Biotech USA Inc.	1	$23
Adaptive Biotechnologies Corporation	1	$22
GE HealthCare	1	$21
Pharmacosmos Therapeutics Inc.	1	$21
Epizyme, Inc.	1	$20
Recordati_rare_diseases_inc.	1	$20
Myriad Genetic Laboratories, Inc.	1	$17
ADC Therapeutics America, Inc.	1	$16
Beone Medicines USA, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Oncology$262

How this compares

$9,096 in reported general payments places this provider in the 80th percentile of 418 radiation oncology providers in Texas.

See all radiation oncology providers in Texas →

Medicare billing

Part B allowed, 2024

$1,314,328

Medicare patients

268

Services billed

7,202

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tramadol Hcl	13	$35
Tamsulosin Hcl	12	$30

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Plano

James PetrikasPlano$359K
Daniel GomezHouston$8.7M
Neil DesaiDallas$8.6M
Chad TangHouston$7.7M
James WelshHouston$5.1M
Caroline ChungHouston$3.7M
Karen HoffmanHouston$2.6M
Clifton FullerHouston$1.6M
Robert TimmermanDallas$1.5M
Steven LinHouston$1.5M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →